US 9222086
Compositions and methods for silencing genes expressed in cancer
granted A61KA61K31/7105A61K31/713
Quick answer
US patent 9222086 (Compositions and methods for silencing genes expressed in cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7105, A61K31/713, A61P, A61P35/00